DE602004030451D1 - Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion - Google Patents
Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktionInfo
- Publication number
- DE602004030451D1 DE602004030451D1 DE602004030451T DE602004030451T DE602004030451D1 DE 602004030451 D1 DE602004030451 D1 DE 602004030451D1 DE 602004030451 T DE602004030451 T DE 602004030451T DE 602004030451 T DE602004030451 T DE 602004030451T DE 602004030451 D1 DE602004030451 D1 DE 602004030451D1
- Authority
- DE
- Germany
- Prior art keywords
- igm
- production
- quantifying
- transformed cells
- chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 238000000034 method Methods 0.000 title abstract 2
- 101000840258 Homo sapiens Immunoglobulin J chain Proteins 0.000 abstract 2
- 102100029571 Immunoglobulin J chain Human genes 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- 238000012761 co-transfection Methods 0.000 abstract 1
- 238000011002 quantification Methods 0.000 abstract 1
- 238000000926 separation method Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/30—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells
- C07K16/3076—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties
- C07K16/3084—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants from tumour cells against structure-related tumour-associated moieties against tumour-associated gangliosides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6854—Immunoglobulins
- G01N33/686—Anti-idiotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/52—Constant or Fc region; Isotype
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/73—Inducing cell death, e.g. apoptosis, necrosis or inhibition of cell proliferation
- C07K2317/734—Complement-dependent cytotoxicity [CDC]
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Hematology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Food Science & Technology (AREA)
- Microbiology (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US48733303P | 2003-07-15 | 2003-07-15 | |
PCT/JP2004/010444 WO2005005636A1 (ja) | 2003-07-15 | 2004-07-15 | 形質転換細胞によるIgMの産生とその定量方法 |
Publications (1)
Publication Number | Publication Date |
---|---|
DE602004030451D1 true DE602004030451D1 (de) | 2011-01-20 |
Family
ID=34062150
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DE602004030451T Expired - Lifetime DE602004030451D1 (de) | 2003-07-15 | 2004-07-15 | Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm-produktion |
Country Status (9)
Country | Link |
---|---|
US (2) | US7709615B2 (de) |
EP (2) | EP1652925B1 (de) |
JP (1) | JP5452835B2 (de) |
AT (1) | ATE490787T1 (de) |
AU (1) | AU2004256354B2 (de) |
CA (1) | CA2532966C (de) |
DE (1) | DE602004030451D1 (de) |
TW (1) | TW200510532A (de) |
WO (1) | WO2005005636A1 (de) |
Families Citing this family (36)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP5452835B2 (ja) * | 2003-07-15 | 2014-03-26 | 中外製薬株式会社 | 形質転換細胞によるIgMの産生とその定量方法 |
ATE518888T1 (de) * | 2003-10-09 | 2011-08-15 | Chugai Pharmaceutical Co Ltd | Stabilisierte lösung mit hoher igm-konzentration |
JP4671864B2 (ja) | 2003-10-09 | 2011-04-20 | 中外製薬株式会社 | タンパク質溶液の安定化方法 |
EP1835022B1 (de) * | 2005-01-05 | 2015-02-11 | Chugai Seiyaku Kabushiki Kaisha | Zellkulturverfahren und dessen nutzung |
WO2007002676A2 (en) * | 2005-06-27 | 2007-01-04 | Invitrogen Corporation | Liquid protein markers for native gel electrophoresis |
FR2888850B1 (fr) | 2005-07-22 | 2013-01-11 | Pf Medicament | Nouveaux anticorps anti-igf-ir et leurs applications |
EP1977763A4 (de) | 2005-12-28 | 2010-06-02 | Chugai Pharmaceutical Co Ltd | Antikörper-enthaltende stabilisierende zubereitung |
PT1981540E (pt) * | 2006-01-30 | 2013-05-07 | Grifols Therapeutics Inc | Método de tratamento e profilaxia de doenças relacionadas com a deposição de amilóides utilizando igm |
CA2654623C (en) | 2006-06-08 | 2016-07-26 | Chugai Seiyaku Kabushiki Kaisha | An anti-nr10/il-31ra antibody for use in preventing or treating an inflammatory disease |
HU0700534D0 (en) | 2006-11-24 | 2007-10-29 | Mezoegazdasagi Biotechnologiai | Transgenic animal with enhanced immune response and method for the preparation thereof |
MX2010004007A (es) | 2007-10-15 | 2010-06-15 | Chugai Pharmaceutical Co Ltd | Metodo para la produccion de un anticuerpo. |
MX2010006097A (es) | 2007-12-05 | 2010-08-04 | Chugai Pharmaceutical Co Ltd | Agentes terapeuticos para tratar el prurito. |
PE20091174A1 (es) | 2007-12-27 | 2009-08-03 | Chugai Pharmaceutical Co Ltd | Formulacion liquida con contenido de alta concentracion de anticuerpo |
US8278065B2 (en) * | 2008-06-30 | 2012-10-02 | Morphotek, Inc. | Polynucleotides encoding anti-GD2 antibodies |
JP5232241B2 (ja) * | 2008-10-31 | 2013-07-10 | 独立行政法人科学技術振興機構 | ヘルパーt細胞の選択的機能制御法 |
AR080428A1 (es) | 2010-01-20 | 2012-04-11 | Chugai Pharmaceutical Co Ltd | Formulaciones liquidas estabilizadas contentivas de anticuerpos |
EP2735315B1 (de) | 2011-07-19 | 2019-10-02 | Chugai Seiyaku Kabushiki Kaisha | Proteinhaltige stabile zubereitung mit argininamid oder valinamid |
KR101993488B1 (ko) | 2011-09-01 | 2019-06-26 | 추가이 세이야쿠 가부시키가이샤 | 한외여과에 의해 고도로 농축된 항체를 포함하는 조성물의 제조 방법 |
BR112014025898A2 (pt) * | 2012-04-17 | 2017-11-07 | Mayo Found Medical Education & Res | anticorpos humanos e sequências de ligação específica, para uso em acidente vascular cerebral e isquemia ou condições isquêmicas |
EP2925783B1 (de) * | 2012-11-30 | 2020-07-29 | Katinger GmbH | Rekombinanter humaner igm antikoerper effektiv gegen krebszellen |
US20140199319A1 (en) * | 2012-12-14 | 2014-07-17 | Abbvie, Inc. | Methods for increasing the efficiency of hybridoma generation |
KR102344170B1 (ko) | 2013-12-27 | 2021-12-27 | 추가이 세이야쿠 가부시키가이샤 | 등전점이 낮은 항체의 정제방법 |
ES2887299T3 (es) | 2014-04-03 | 2021-12-22 | Igm Biosciences Inc | Cadena J modificada |
US20170362304A1 (en) | 2014-08-20 | 2017-12-21 | Chugai Seiyaku Kabushiki Kaisha | Method for measuring viscosity of protein solution |
EP3750918A1 (de) | 2015-01-20 | 2020-12-16 | IGM Biosciences, Inc. | Tumornekrosefaktor-superfamilienrezeptorbindende moleküle und verwendungen davon |
DK3265575T3 (da) | 2015-03-04 | 2021-05-31 | Igm Biosciences Inc | Cd20-bindende molekyler og anvendelser deraf |
AU2016238246B2 (en) * | 2015-03-25 | 2021-05-13 | Igm Biosciences, Inc. | Multi-valent hepatitis B virus antigen binding molecules and uses thereof |
US10618978B2 (en) | 2015-09-30 | 2020-04-14 | Igm Biosciences, Inc. | Binding molecules with modified J-chain |
US11639389B2 (en) | 2015-09-30 | 2023-05-02 | Igm Biosciences, Inc. | Binding molecules with modified J-chain |
US10572893B2 (en) | 2016-06-16 | 2020-02-25 | International Business Machines Corporation | Discovering and interacting with proximate automobiles |
JPWO2019225568A1 (ja) | 2018-05-21 | 2021-07-01 | 中外製薬株式会社 | ガラス容器に封入された凍結乾燥製剤 |
JP6955098B2 (ja) | 2018-05-28 | 2021-10-27 | 中外製薬株式会社 | 充填ノズル |
EP4003333A4 (de) * | 2019-07-31 | 2023-11-01 | The Wistar Institute for Anatomy and Biology | Multivalente dna-antikörperkonstrukte und ihre verwendung |
MX2022013334A (es) * | 2020-04-22 | 2022-12-06 | Igm Biosciences Inc | Moleculas de union multimerica de agonistas de pd-1. |
EP4297786A1 (de) * | 2021-02-23 | 2024-01-03 | Pandion Operations, Inc. | Pd-1-antikörper, polypeptide und verwendungen davon |
WO2023064841A1 (en) * | 2021-10-13 | 2023-04-20 | The Wistar Institute Of Anatomy And Biology | Antibodies for use against sars-cov-2 |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5156840A (en) | 1982-03-09 | 1992-10-20 | Cytogen Corporation | Amine-containing porphyrin derivatives |
US5057313A (en) | 1986-02-25 | 1991-10-15 | The Center For Molecular Medicine And Immunology | Diagnostic and therapeutic antibody conjugates |
US5157113A (en) * | 1987-08-10 | 1992-10-20 | Miles Inc. | Removal of nucleic acids from monoclonal antibody preparations |
DE3875852T2 (de) | 1987-08-10 | 1993-03-18 | Miles Inc | Gereinigtes igm. |
GB8719963D0 (en) * | 1987-08-24 | 1987-09-30 | Cattaneo A | Recombinant dna products |
US6238891B1 (en) * | 1987-11-18 | 2001-05-29 | Cetus Oncology Corporation | Method of increasing product expression through solute stress |
CA1312030C (en) | 1987-11-18 | 1992-12-29 | Brian Maiorella | Method to increase antibody titer |
JP2501116B2 (ja) | 1988-03-05 | 1996-05-29 | 日本電信電話株式会社 | 巡回制御形回線交換方法 |
DE3825429C2 (de) | 1988-07-27 | 1994-02-10 | Biotest Pharma Gmbh | Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt |
GB9010944D0 (en) | 1990-05-16 | 1990-07-04 | Central Blood Lab Authority | Chemical compounds |
US5419904A (en) * | 1990-11-05 | 1995-05-30 | The Regents Of The University Of California | Human B-lymphoblastoid cell line secreting anti-ganglioside antibody |
JPH05192181A (ja) * | 1990-12-18 | 1993-08-03 | Ishihara Sangyo Kaisha Ltd | ヒトモノクローナル抗体 |
EP0492409A1 (de) | 1990-12-18 | 1992-07-01 | Ishihara Sangyo Kaisha, Ltd. | Menschlicher monoklonaler Antikörper |
JPH0565233A (ja) | 1991-03-08 | 1993-03-19 | Mitsui Toatsu Chem Inc | モノクローナル抗体含有凍結乾燥製剤 |
PT503648E (pt) * | 1991-03-12 | 2000-10-31 | Biogen Inc | Dominio do antigenio 3 associado a funcao linfocitica de ligacao as cd2 |
AU668349B2 (en) | 1991-04-25 | 1996-05-02 | Chugai Seiyaku Kabushiki Kaisha | Reconstituted human antibody against human interleukin 6 receptor |
JPH04360696A (ja) * | 1991-06-06 | 1992-12-14 | Sumitomo Chem Co Ltd | 新規なヒトbリンパ細胞株を宿主として産生された組み換えヒト抗体 |
GB9122820D0 (en) * | 1991-10-28 | 1991-12-11 | Wellcome Found | Stabilised antibodies |
EP0598998B1 (de) * | 1992-09-07 | 2004-05-19 | Kyowa Hakko Kogyo Co., Ltd | Humanisierte Antikörper, die mit dem GM2-Gangliosid reagieren |
JP3565572B2 (ja) | 1992-09-07 | 2004-09-15 | 協和醗酵工業株式会社 | ヒト化抗体 |
JPH06178689A (ja) * | 1992-12-11 | 1994-06-28 | Mitsui Toatsu Chem Inc | I型緑膿菌を抗原とするヒト抗体をコードする遺伝子 |
JPH06189781A (ja) | 1992-12-25 | 1994-07-12 | Mitsui Toatsu Chem Inc | 培養液中の生理活性タンパク質の安定化方法 |
JPH09127112A (ja) | 1995-10-30 | 1997-05-16 | Dainabotsuto Kk | 修飾IgM免疫学的測定試薬 |
JPH09127114A (ja) | 1995-11-01 | 1997-05-16 | Dainabotsuto Kk | 免疫学的測定用安定化IgM試薬 |
ES2221065T3 (es) * | 1996-08-16 | 2004-12-16 | The President And Fellows Of Harvard College | Proteinas de fusion de clase ii del mhc, solubles, monovalentes o polivalentes, y sus usos. |
EP0835880A1 (de) | 1996-10-14 | 1998-04-15 | Rotkreuzstiftung Zentrallaboratorium Blutspendedienst Srk | Verfahren zur Herstellung eines IgM Präparates für die intravenöse Applikation |
JPH10324699A (ja) * | 1997-03-21 | 1998-12-08 | Sankyo Co Ltd | 抗ヒトFasヒト化抗体 |
ZA988461B (en) | 1997-09-18 | 1999-03-30 | Idec Pharma Corp | Synergistic composition and methods for treating neoplastic or cancerous growths and for restoring or boosting hematopoiesis |
AU3544599A (en) * | 1998-01-16 | 1999-08-02 | Paul E. Borchardt | Use of radiolabeled monoclonal igm in therapy for cancer and autoimmune disease |
AU2444899A (en) | 1998-01-22 | 1999-08-09 | Astrazeneca Ab | Pharmaceutical formulation comprising an antibody and a citrate buffer |
CA2321262A1 (en) * | 1998-02-19 | 1999-08-26 | President And Fellows Of Harvard College | Monovalent, multivalent, and multimeric mhc binding domain fusion proteins and conjugates, and uses therefor |
JP2000154149A (ja) * | 1998-09-18 | 2000-06-06 | Sankyo Co Ltd | 抗ヒトFasヒト化抗体含有抗リウマチ剤 |
CN100480266C (zh) * | 1998-10-16 | 2009-04-22 | 拜奥根Idec马萨诸塞公司 | 干扰素-β融合蛋白及用途 |
ES2571230T3 (es) | 1999-04-09 | 2016-05-24 | Kyowa Hakko Kirin Co Ltd | Procedimiento para controlar la actividad de una molécula inmunofuncional |
EP1174148A4 (de) | 1999-04-28 | 2005-05-04 | Yamanouchi Pharma Co Ltd | Parenterale medizinische zusammensetzungen enthaltend fragmente humanisierter monoklonaler antikörper und methode zur stabilisierung derselben |
AU7449200A (en) | 1999-09-30 | 2001-04-30 | Kyowa Hakko Kogyo Co. Ltd. | Derivatives of antibody against ganglioside gm2 |
WO2001033957A1 (fr) * | 1999-11-05 | 2001-05-17 | Kyowa Hakko Kogyo Co., Ltd. | Mammiferes transgeniques non humains de controle du changement de concentration d'ions calcium dans des cellules |
EP1272647B1 (de) * | 2000-04-11 | 2014-11-12 | Genentech, Inc. | Multivalente antikörper und deren verwendung |
US6723606B2 (en) | 2000-06-29 | 2004-04-20 | California Institute Of Technology | Aerosol process for fabricating discontinuous floating gate microelectronic devices |
EP1308509A4 (de) | 2000-08-01 | 2004-05-12 | Kyowa Hakko Kogyo Kk | Neuartiges, physiologisch aktives peptid und dessen anwendungen |
GB0113179D0 (en) * | 2001-05-31 | 2001-07-25 | Novartis Ag | Organic compounds |
JP2003128576A (ja) * | 2001-10-25 | 2003-05-08 | Taisho Pharmaceut Co Ltd | エンドトキシン誘発性疾患治療薬 |
AU2002356749A1 (en) * | 2001-11-28 | 2003-06-10 | Hermann Katinger | Process for the production of polypeptides in mammalian cell cultures |
DE10328295B4 (de) | 2003-06-23 | 2007-11-22 | Endress + Hauser Gmbh + Co. Kg | Verfahren und entsprechende Vorrichtung zum Schweißen von Bauteilen eines Feldgerätes |
WO2005003557A1 (en) | 2003-06-25 | 2005-01-13 | Design Net Engineering, Llc | Laser propulsion thruster |
JP5452835B2 (ja) | 2003-07-15 | 2014-03-26 | 中外製薬株式会社 | 形質転換細胞によるIgMの産生とその定量方法 |
ATE518888T1 (de) | 2003-10-09 | 2011-08-15 | Chugai Pharmaceutical Co Ltd | Stabilisierte lösung mit hoher igm-konzentration |
JP4671864B2 (ja) | 2003-10-09 | 2011-04-20 | 中外製薬株式会社 | タンパク質溶液の安定化方法 |
-
2004
- 2004-07-15 JP JP2005511621A patent/JP5452835B2/ja not_active Expired - Lifetime
- 2004-07-15 DE DE602004030451T patent/DE602004030451D1/de not_active Expired - Lifetime
- 2004-07-15 WO PCT/JP2004/010444 patent/WO2005005636A1/ja active Application Filing
- 2004-07-15 CA CA2532966A patent/CA2532966C/en not_active Expired - Lifetime
- 2004-07-15 EP EP04747833A patent/EP1652925B1/de not_active Expired - Lifetime
- 2004-07-15 EP EP10150954A patent/EP2204190A1/de not_active Withdrawn
- 2004-07-15 US US10/564,665 patent/US7709615B2/en active Active
- 2004-07-15 AU AU2004256354A patent/AU2004256354B2/en not_active Expired
- 2004-07-15 TW TW093121127A patent/TW200510532A/zh unknown
- 2004-07-15 AT AT04747833T patent/ATE490787T1/de not_active IP Right Cessation
-
2010
- 2010-03-18 US US12/727,162 patent/US8257703B2/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
US7709615B2 (en) | 2010-05-04 |
JPWO2005005636A1 (ja) | 2006-08-24 |
US20070154469A1 (en) | 2007-07-05 |
AU2004256354B2 (en) | 2011-07-07 |
EP1652925A4 (de) | 2007-07-04 |
EP1652925A1 (de) | 2006-05-03 |
EP1652925B1 (de) | 2010-12-08 |
ATE490787T1 (de) | 2010-12-15 |
EP2204190A1 (de) | 2010-07-07 |
JP5452835B2 (ja) | 2014-03-26 |
AU2004256354A1 (en) | 2005-01-20 |
WO2005005636A1 (ja) | 2005-01-20 |
US8257703B2 (en) | 2012-09-04 |
CA2532966C (en) | 2012-12-04 |
TWI342336B (de) | 2011-05-21 |
US20100172899A1 (en) | 2010-07-08 |
TW200510532A (en) | 2005-03-16 |
CA2532966A1 (en) | 2005-01-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE490787T1 (de) | Produktion von igm durch transformierte zellen und verfahren zur quantifizierung dieser igm- produktion | |
ATE514717T1 (de) | Rekombinante produktion von antikörpermischungen | |
DE60224643D1 (de) | Verfahren zur herstellung von reifen | |
PL2314621T3 (pl) | Cząsteczki wiążące zdolne do neutralizowania wirusa wścieklizny i ich zastosowania | |
WO2004022714A3 (en) | Organic species that facilitate charge transfer to or from nanostructures | |
ATE340174T1 (de) | Verfahren zur umwandlung von dihidroisoxazol derivate in gamma-hydroxaminsäurederivate, z.b monatins | |
ATE469223T1 (de) | Pilz transkriptionsaktivator zur verwendung in verfahren zur herstellung von polypeptiden | |
WO2007044066A3 (en) | Methods for normalizing and for identifying small nucleic acids | |
WO2005116213A3 (en) | Directed evolution of proteins | |
ATE458044T1 (de) | Verfahren zur nukleinsäureamplifikation | |
DE602005025002D1 (de) | Verfahren zur herstellung von brenztraubensäure | |
DE502004005626D1 (de) | Verfahren zur herstellung von organoacylphosphiten | |
DE60331111D1 (de) | Verfahren zur Herstellung von martensitaushärtendem Stahl | |
DE50302740D1 (de) | Verfahren zur herstellung von verküpbaren organischen pigmenten | |
ATE336464T1 (de) | Verfahren zur aufreinigung von blausäure | |
DE60331043D1 (de) | Verfahren zur entfernung von dithiogruppen aus polymerkettenenden | |
ATE548395T1 (de) | Verfahren zur herstellung von polyolefinen in suspension | |
ATE290076T1 (de) | Ein verfahren zur trennung und reinigung von rna | |
DE602004000126D1 (de) | Verfahren zur Herstellung von selbststanzenden Muttern | |
DE60200012D1 (de) | Verfahren zur Herstellung von Luftreifen | |
DE502004009623D1 (de) | Verfahren zur herstellung von leder unter verwendung von polymerisaten | |
ATE420168T1 (de) | Verfahren zur herstellung von extrachromosomalen nukleinsäuremolekülen | |
ATE444304T1 (de) | Verfahren zur herstellung von tripeptid- zwischenprodukten zur herstellung von lhrh- antagonisten | |
DE50301977D1 (de) | Verfahren zur Herstellung von gehärteten Bauteilen aus Stahl | |
DE50313133D1 (de) | Verfahren zur erkennung von reifeneigenschaften |